Erythropoietin-regulated oxidative stress negatively affects enucleation during terminal erythropoiesis

Exp Hematol. 2016 Oct;44(10):975-81. doi: 10.1016/j.exphem.2016.06.249. Epub 2016 Jun 27.

Abstract

Differentiating erythroblasts are exposed to an oxidative environment. The dynamics of oxidative status during terminal erythropoiesis and how they affect cell differentiation in response to erythropoietin (Epo) are unclear. Here, we show that Epo induces reactive oxygen species (ROS) production in the early stages of terminal erythropoiesis. The levels of ROS correlate with CD71 surface expression and the uptake of iron and transferrin. ROS decreases in the late stages of terminal erythropoiesis, when the cells are preparing for enucleation. Consistently, treatment of erythroblasts with a low dose (5 mM) of N-acetyl-cysteine (NAC), a ROS scavenger, promotes enucleation. However, a high dose (20 mM) of NAC leads to significant cell death. Our study reveals an important function of Epo in regulating the dynamics of oxidative status and enucleation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Apoptosis
  • Biomarkers
  • Cell Differentiation / drug effects*
  • Erythroblasts / cytology*
  • Erythroblasts / drug effects*
  • Erythroblasts / metabolism
  • Erythropoiesis / drug effects*
  • Erythropoietin / pharmacology*
  • Fetus
  • Hematopoietic Cell Growth Factors / pharmacology
  • Hemoglobins / metabolism
  • Immunophenotyping
  • Iron / metabolism
  • Liver / cytology
  • Mice
  • Oxidative Stress / drug effects
  • Reactive Oxygen Species / metabolism
  • Transferrin / metabolism

Substances

  • Biomarkers
  • Hematopoietic Cell Growth Factors
  • Hemoglobins
  • Reactive Oxygen Species
  • Transferrin
  • Erythropoietin
  • Iron